Association of butyric acid produced by periodontopathic bacteria with progression of oral cancer

Journal of Cancer Science and Therapy

Volumn 2, Issue 2, 2010, Pages 26-32

  Miyazaki, Yuji ^a   Kikuchi, Kentaro ^a   González Alva, Patricia ^a   Inoue, Harumi ^a   Noguchi, Yoshihiro ^a   Tsuchiya, Hozumi ^a   Hayashi, Joichiro ^a   Shin, Kitetsu ^a   Ochiai, Kuniyasu ^b   Kusama, Kaoru ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Butyric acid sodium butyrate; Cell migration; Epithelial mesenchymal transition; Oral squamous cell carcinoma; Podoplanin

Indexed keywords

BUTYRIC ACID; PODOPLANIN; SMALL INTERFERING RNA; VIMENTIN;

ARTICLE; BACTERIUM; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MOUTH CANCER; PERIODONTOPATHIC BACTERIA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 77954676716     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000019     Document Type: Article

References (30)

1. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, et al. (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48: 3282-3287.
2. Boucherot A, Schreiber R, Pavenstädt H, Kunzelmann K (2002) Cloning and expression of the mouse glomerular podoplanin homologue gp38P. Nephrol Dial Transplant 17: 978-984.
3. Durchdewald M, Guinea-Viniegra J, Haag D, Riehl A, Lichter P, et al. (2008) Podoplanin is a novel fos target gene in skin carcinogenesis. Cancer Res 68: 6877-6883.
4. Eveson JW, Kusafuka K, Stenman G, Nagao T (2005) Pleomorphic adenoma. In: Barnes L, Evenson JW, Reichart PA, Sidransky D (eds) WHO classification of tumours. Pathology and genetics. Head and neck tumours. Lyon: IARC 254-258.
5. Farrow B, Rychahou P, O'Connor KL, Evers BM (2003) Butyrate inhibits pancreatic cancer invasion. J Gastrointest Surg 7: 864-870.
6. Gardner DG, Heikinheimo K, Shear M, Philipsen HP, Coleman H (2005) Ameloblastomas. In: Barnes L, Evenson JW, Reichart PA, Sidransky D (eds) WHO classification of tumours. Pathology and genetics. Head and neck tumours. Lyon: IARC 296-300.
7. González-Alva P, Tanaka A, Oku Y, Miyazaki Y, Okamoto E, et al. (2010) Enhanced expression of podoplanin in ameloblastomas. J Oral Pathol Med 39: 103-109.
8. Hantusch B, Kalt R, Krieger S, Puri C, Kerjaschki D (2007) Sp1/Sp3 and DNAmethylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC Mol Biol 7: 8-20.
9. Hirakawa S, Hong YK, Harvey N, Schacht V, Matsuda K, et al. (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 162: 575-586.
10. Imai K, Ochiai K, Okamoto T (2009) Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol 182: 3688-3695.
11. Johnson N, Schmid S, Franceschi S (2005) Squamous cell carcinoma. In: Barnes L, Evenson JW, Reichart PA, Sidransky D (eds) WHO classification of tumours. Pathology and genetics. Head and neck tumours. Lyon: IARC 168-175.
12. Kaneko M, Kato Y, Kunita A, Fujita N, Tsuruo T, et al. (2004) Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells. J Biol Chem 279: 38838-38843.
13. Kurita-Ochiai T, Seto S, Suzuki N, Yamamoto M, Otsuka K, et al. (2008) Butyric acid induces apoptosis in inflamed fibroblasts. J Dent Res 87: 51-55.
14. Martín-Villar E, Megías D, Castel S, Yurrita MM, Vilaró S, et al. (2006) Podoplanin binds ERM proteins to activate RhoA and promote epithelialmesenchymal transition. J Cell Sci 119: 4541-4553.
15. Matsui K, Breiteneder-Geleff S, Kerjaschki D (1998) Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin causes proteinuria and rapid flattening of podocytes. J Am Soc Nephrol 9: 2013-2026.
16. Michaud DS, Liu Y, Meyer M, Glovannucci E, Joshipura K (2008) Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study. Lancet Oncol 9: 550-558.
17. Miyazaki Y, Okamoto E, González-Alva P, Hayashi J, Ishige T, et al. (2009) The significance of podoplanin expression in human inflamed gingival. J Oral Sci 51: 283-287.
18. Ochiai K, Kurita-Ochiai T (2009). Effects of butyric acid on the periodontal tissue. Jpn Dent Sci Rev 45: 75-82.
19. Okamoto E, Kikuchi K, Miyazaki Y, González-Alva P, Oku Y, et al. (2009) Signifiicance of podoplanin expression in keratocystic odontogenic tumor. J Oral Pathol Med 39: 110-114.
20. Oku Y, Tanaka A, González-Alva P, Sakashita H, Kusama K (2008) Podoplanin expression in human pleomorphic adenomas. In: Varma AK, Qiu WL (eds) Oral Oncology, Vol. 12. Shanghai: Ocean Papers & Printers 251-253.
21. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP (1997) Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79: 595-604.
22. Philipsen HP (2005) Keratocystic odontogenic tumour. In: Barnes L, Evenson JW, Reichart PA, Sidransky D (eds) WHO classification of tumours. Pathology and genetics. Head and neck tumours. Lyon: IARC Press 306-307.
23. Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal disease. Lancet 366: 1809-1820.
24. Pulukuri SMK, Gorantla B, Rao JS (2007) Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator. J Biol Chem 282: 35594-35603.
25. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, et al. (2005) Upregulation of the lymphatic marker podoplanin, a mutin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166: 913-921.
26. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, et al. (2009) Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 18: 2406-2412.
27. Tichonicky L, Kruh J, Defer N (1990) Sodium butyrate inhibits c-myc and stimulates c-fos expression in all the steps of the cell-cycle in hepatoma tissue cultured cells. Biol Cell 69: 65-67.
28. Wang XM, Li J, Evers BM (1999) Inhibition of proliferation, invasion and adhesion of liver cancer cells by 5-azacytidine and butyrate. Anticancer Res 19: 2901-2906.
29. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, et al. (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplaninmediated remodeling of the actin cytoskeleton. Cancer Cell 9: 261-272.
30. Wilson AJ, Gibson PR (1997) Short-chain fatty acids promote the migration of colonic epithelial cells in vitro. Gastroenterology 113: 487-496.